Cargando…

Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients

End-stage kidney disease is preferably treated by kidney transplantation. The suboptimal function of the allograft often results in misbalances in kidney-controlled processes and requires long-term monitoring of allograft function and viability. As the kidneys are organs with a very high metabolomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranovicova, Eva, Vnucak, Matej, Granak, Karol, Lehotsky, Jan, Kadasova, Nina, Miklusica, Juraj, Dedinska, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318187/
https://www.ncbi.nlm.nih.gov/pubmed/35888785
http://dx.doi.org/10.3390/metabo12070661
_version_ 1784755230615797760
author Baranovicova, Eva
Vnucak, Matej
Granak, Karol
Lehotsky, Jan
Kadasova, Nina
Miklusica, Juraj
Dedinska, Ivana
author_facet Baranovicova, Eva
Vnucak, Matej
Granak, Karol
Lehotsky, Jan
Kadasova, Nina
Miklusica, Juraj
Dedinska, Ivana
author_sort Baranovicova, Eva
collection PubMed
description End-stage kidney disease is preferably treated by kidney transplantation. The suboptimal function of the allograft often results in misbalances in kidney-controlled processes and requires long-term monitoring of allograft function and viability. As the kidneys are organs with a very high metabolomic rate, a metabolomics approach is suitable to describe systematic changes in post-transplant patients and has great potential for monitoring allograft function, which has not been described yet. In this study, we used blood plasma samples from 55 patients after primary kidney transplantation identically treated with immunosuppressants with follow-up 50 months in the mean after surgery and evaluated relative levels of basal plasma metabolites detectable by NMR spectroscopy. We were looking for the correlations between circulating metabolites levels and allograft performance and allograft rejection features. Our results imply a quantitative relationship between restricted renal function, insufficient hydroxylation of phenylalanine to tyrosine, lowered renal glutamine utilization, shifted nitrogen balance, and other alterations that are not related exclusively to the metabolism of the kidney. No link between allograft function and energy metabolism can be concluded, as no changes were found for glucose, glycolytic intermediates, and 3-hydroxybutyrate as a ketone body representative. The observed changes are to be seen as a superposition of changes in the comprehensive inter-organ metabolic exchange, when the restricted function of one organ may induce compensatory effects or cause secondary alterations. Particular differences in plasma metabolite levels in patients with acute cellular and antibody-mediated allograft rejection were considered rather to be related to the loss of kidney function than to the molecular mechanism of graft rejection since they largely follow the alterations observed by restricted allograft function. In the end, we showed using a simple mathematical model, multilinear regression, that the basal plasmatic metabolites correlated with allograft function expressed by the level of glomerular filtration rate (with creatinine: p-value = 4.0 × 10(−26) and r = 0.94, without creatinine: p-value = 3.2 × 10(−22) and r = 0.91) make the noninvasive estimation of the allograft function feasible.
format Online
Article
Text
id pubmed-9318187
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93181872022-07-27 Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients Baranovicova, Eva Vnucak, Matej Granak, Karol Lehotsky, Jan Kadasova, Nina Miklusica, Juraj Dedinska, Ivana Metabolites Article End-stage kidney disease is preferably treated by kidney transplantation. The suboptimal function of the allograft often results in misbalances in kidney-controlled processes and requires long-term monitoring of allograft function and viability. As the kidneys are organs with a very high metabolomic rate, a metabolomics approach is suitable to describe systematic changes in post-transplant patients and has great potential for monitoring allograft function, which has not been described yet. In this study, we used blood plasma samples from 55 patients after primary kidney transplantation identically treated with immunosuppressants with follow-up 50 months in the mean after surgery and evaluated relative levels of basal plasma metabolites detectable by NMR spectroscopy. We were looking for the correlations between circulating metabolites levels and allograft performance and allograft rejection features. Our results imply a quantitative relationship between restricted renal function, insufficient hydroxylation of phenylalanine to tyrosine, lowered renal glutamine utilization, shifted nitrogen balance, and other alterations that are not related exclusively to the metabolism of the kidney. No link between allograft function and energy metabolism can be concluded, as no changes were found for glucose, glycolytic intermediates, and 3-hydroxybutyrate as a ketone body representative. The observed changes are to be seen as a superposition of changes in the comprehensive inter-organ metabolic exchange, when the restricted function of one organ may induce compensatory effects or cause secondary alterations. Particular differences in plasma metabolite levels in patients with acute cellular and antibody-mediated allograft rejection were considered rather to be related to the loss of kidney function than to the molecular mechanism of graft rejection since they largely follow the alterations observed by restricted allograft function. In the end, we showed using a simple mathematical model, multilinear regression, that the basal plasmatic metabolites correlated with allograft function expressed by the level of glomerular filtration rate (with creatinine: p-value = 4.0 × 10(−26) and r = 0.94, without creatinine: p-value = 3.2 × 10(−22) and r = 0.91) make the noninvasive estimation of the allograft function feasible. MDPI 2022-07-18 /pmc/articles/PMC9318187/ /pubmed/35888785 http://dx.doi.org/10.3390/metabo12070661 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Baranovicova, Eva
Vnucak, Matej
Granak, Karol
Lehotsky, Jan
Kadasova, Nina
Miklusica, Juraj
Dedinska, Ivana
Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients
title Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients
title_full Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients
title_fullStr Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients
title_full_unstemmed Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients
title_short Circulating Metabolites in Relation to the Kidney Allograft Function in Posttransplant Patients
title_sort circulating metabolites in relation to the kidney allograft function in posttransplant patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318187/
https://www.ncbi.nlm.nih.gov/pubmed/35888785
http://dx.doi.org/10.3390/metabo12070661
work_keys_str_mv AT baranovicovaeva circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients
AT vnucakmatej circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients
AT granakkarol circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients
AT lehotskyjan circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients
AT kadasovanina circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients
AT miklusicajuraj circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients
AT dedinskaivana circulatingmetabolitesinrelationtothekidneyallograftfunctioninposttransplantpatients